IRIS
LAZZARIN, ADRIANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.232
NA - Nord America 832
AS - Asia 568
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 5
AF - Africa 4
OC - Oceania 1
Totale 2.651
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 824
SE - Svezia 715
CN - Cina 275
SG - Singapore 250
IT - Italia 190
RU - Federazione Russa 190
FI - Finlandia 55
IN - India 27
DE - Germania 26
IE - Irlanda 18
NL - Olanda 8
CA - Canada 7
GB - Regno Unito 7
EU - Europa 5
MD - Moldavia 5
BE - Belgio 4
BR - Brasile 4
CZ - Repubblica Ceca 3
HK - Hong Kong 3
IR - Iran 3
TH - Thailandia 3
CL - Cile 2
FR - Francia 2
JP - Giappone 2
LT - Lituania 2
TN - Tunisia 2
UA - Ucraina 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
DK - Danimarca 1
EC - Ecuador 1
ES - Italia 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
TR - Turchia 1
Totale 2.651
Salva come PNG Salva come JPEG
Città #
Lawrence 219
Princeton 219
Singapore 154
Moscow 102
Milan 97
Ashburn 78
Shanghai 78
New York 74
Helsinki 50
Boardman 38
Pune 22
Guangzhou 20
Dublin 15
Rome 13
Beijing 10
Shenzhen 10
Los Angeles 9
Seattle 8
Washington 8
Dallas 6
Quanzhou 6
Chisinau 5
Wuyuan 5
Borås 4
Hamilton 4
Ortezzano 4
West Jordan 4
Wuxi 4
Angera 3
Ballincollig 3
Curitiba 3
Espoo 3
Kassel 3
Nuremberg 3
Padova 3
Santa Clara 3
Xi'an 3
Bangkok 2
Brussels 2
Dalian 2
Duchcov 2
Durban 2
Florence 2
Ghent 2
Hanover 2
Hyderabad 2
Lappeenranta 2
London 2
Panchkula 2
Povegliano 2
Redwood City 2
Segrate 2
St Petersburg 2
Taizhou 2
Tehran 2
Tokyo 2
Torre Del Greco 2
Tualatin 2
Turin 2
Vittoria 2
Wanchai 2
Almaty 1
Amsterdam 1
Baoding 1
Belgrade 1
Buffalo 1
Campodolcino 1
Castelletto sopra Ticino 1
Castiglion Fiorentino 1
Cesano Maderno 1
Dalmine 1
Dhaka 1
Dongguan 1
Dongyang 1
Falkenstein 1
Fuzhou 1
Gatchina 1
Giussano 1
Haining 1
Haywards Heath 1
Henderson 1
Isfahan 1
Jiaxing 1
Jinhua 1
Kunshan 1
Kuwait City 1
La Paz 1
Lainate 1
Lisbon 1
Louth 1
Madignano 1
Madrid 1
Mountain View 1
Munich 1
Noli 1
Paliano 1
Parma 1
Pavia 1
Perm 1
Perugia 1
Totale 1.380
Salva come PNG Salva come JPEG
Nome #
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 51
The 118I reverse transcriptase mutation is the only independent genotypic predictor of virologic failure to a stavudine-containing salvage therapy in HIV-1-infected patients 48
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 43
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 33
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 32
Biobanking for COVID-19 research 30
HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts 28
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 28
VIRO-immunological outcomes after 13-valent pneumococcal vaccination in HIV-1-infected individuals on stable virological suppression 26
Western blot in treated people with HIV-1 chronic infection: frequency of negative HIV-1 pol genes 25
A comparision of brain biopsy and CSF-PCR in the diagnosis of CNS lesions in AIDS patients 25
Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission 24
INCREASED RISK OF DEATH AMONG HIV/HCV CO-INFECTED PATIENTS WITH NON-HODGKIN'S LYMPHOMA 24
Circulating cathodic antigen (CCA) urine rapid test for diagnosis of Schistosoma mansoni infestation: preliminary data of a cohort study of Egyptian patients coming from an endemic area 24
Early diagnosis of HIV infection in infants 23
Dynamics of adaptive and innate immunity inpatients treated during primary human immunodeficiency virus infection: Results from Maraviroc in HIV Acute Infection (MAIN) randomized clinical trial 23
Dynamics of HIV-1 POL antibodies after ART in chronic HIV-1 infection 23
Analytical treatment interruption in chronic HIV-1 infection: Time and magnitude of viral rebound in adults with 10 years of undetectable viral load and low HIV-DNA (APACHE study) 22
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study) 22
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients 22
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS). 21
48 week outcomes of maraviroc-containing regimens following the genotypic or Trofile assay in HIV-1 failing subjects: the OSCAR Study 21
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study) 21
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients 21
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical Practice 20
Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption 20
Morphogenesis, evolution and prognostic significance of lymphatic tissue lesions in HIV infection 20
Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women. 20
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic 20
ABC of AIDS: Treatment of infections and antiviral agents 20
Immunological status in heroin addicts: effects of methadone maintenance treatment 19
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 18
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection 18
Zidovudine and frequency of HIV-induced diffuse leukoencephalopathy 18
Therapeutic trials with HPA23, alpha-IFN and ribavirin in AIDS patients 18
Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus 18
Beneficial effects of cART initiated during primary and chronic HIV-1 infection on immunoglobulin-expression of memory B-cell subsets 18
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial 18
Impact of HAART on liver histology of HIV/HCV coinfected patients 17
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination 17
Bictegravir 17
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 17
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens 17
Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015 17
Efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate as treatment for primary or recent HIV infection-authors' response 16
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients 16
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients 16
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 16
An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study 16
Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy 16
A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study 16
Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males 16
Drop in CD4+ Counts Below 200 Cells/μL After Reaching (or Starting From) Values Higher than 350 Cells/μL in HIV-Infected Patients With Virological Suppression 16
Dynamics of the M184V mutation by allele-specific PCR (AS-PCR) in patients receiving lamivudine or emtricitabine monotherapy or undergoing treatment interruption (TI) 16
GB Virus C and Survival in Persons with HIV Infection 15
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients 15
Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor-Based Combination Antiretroviral Therapy: The D:A:D Study 15
Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological Suppression 15
Estimated glomerular filtration rate trajectories in HIV-infected subjects treated with different ritonavir-boosted protease inhibitors and tenofovir disoproxil fumarate or abacavir 15
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 15
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 15
Exercise ECG for coronary artery disease screening in people living with HIV: The cordis STUDY 15
Evaluation of total HIV-DNA changes in HIV-1 infected patients who continue a 2-drug regimen with dolutegravir plus one reverse transcriptase inhibitor or switch to elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide enrolled in the Be-One Study 15
HEFFICON: HIV Effectiveness Italian Conference 15
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 15
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy 14
Experiences with immunomodulant agents in HIV infections 14
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women 14
Clinical and epidemiological aspects of the first 50 cases of AIDS in Milan 14
Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitors 14
Increased hyperglycaemia during cotreatment with pentamidine and corticosteroids in AIDS patients 14
Diagnosis of toxoplasmic encephalitis in HIV-infected patients 14
Associations of statins and antiretroviral drugs with the onset of type 2 diabetes among HIV-1-infected patients 14
Cytomegalovirus infection of the central nervous system in patients with aids: Diagnosis by DNA amplification from cerebrospinal fluid 14
Evaluation of contrast-enhancing brain lesions in AIDS patients by means of Epstein-Barr virus detection in cerebrospinal fluid and 201thallium single photon emission tomography 14
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015 14
Risk of HIV infection in recipients of blood and blood products 14
Liver-related death among HIV/hepatitis C virus-co-infected individuals: Implications for the era of directly acting antivirals 14
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 14
Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort 14
Reduced frequency of HIV-induced brain lesions in AIDS patients treated with zidovudine 14
Carotid vessels lesions in experienced HIV-1-infected subjects affected or not by hypertension and/or diabetes mellitus 14
Risk of HIV-related diseases in heterosexuals importing infection from Zaire 13
The thymic hormones in the treatment of immune deficiency related to HIV infection 13
Impairment of in vitro natural antibacterial activity in HIV-infected patients 13
Dynamic of Mixed HCV Infection in Plasma and PBMC of HIV/HCV Patients Under Treatment With Peg-IFN/Ribavirin 13
T-lymphocyte subsets and delayed type hypersensitivity as classification parameters for HIV infection among drug-addicts 13
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 13
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2016 13
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism 13
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 13
FAILURE TO DARUNAVIR/RITONAVIR CAN EITHER INCREASE OR DECREASE TIPRANAVIR/RITONAVIR GENOTYPIC RESISTANCE SCORE IN HIGHLY TREATMENT-EXPERIENCED HIV-INFECTED PATIENTS 13
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 13
Analysis of impediments to the maintenance in care of people with HIV in Italy 13
Long-term suppression of viral replication in HIV-related lymphoma survivors: a case-control study 13
Reply 13
Durability of a novel salvage therapy in R5 HIV-infected patients: maraviroc, raltegravir, etravirine 13
Early Diagnosis and Linkage to Care: an Experience over 14 years of Point of Care Rapid HIV Testing 12
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study) 12
Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease 12
Totale 1.821
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/202191 0 0 1 6 0 14 11 57 1 0 1 0
2021/2022145 0 0 0 77 6 8 8 13 10 7 3 13
2022/20231.203 483 292 102 7 10 125 33 85 48 1 11 6
2023/2024605 7 29 81 49 45 137 13 68 0 15 80 81
2024/2025657 375 58 37 82 83 22 0 0 0 0 0 0
Totale 2.905